PPARG and metabolic dysfunction-associated steatotic liver disease: This multi-modality map of pediatric NAFLD provides a context for potentially understanding the different effects of medications on the disease course and progression, such as vitamin E versus PPAR-γ agonists, chemokine receptor antagonists, and other emerging medications [6,22,24].